JPRN-UMIN000000672已完成未知
Prediction of drug adverse event through gene expression analysis - Prediction of drug adverse event through gene expression analysis
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 60years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •renal dysfunction (Creatinin equal or greater than 2.0 mg/dl) liver dysfunction (ALT, AST, T-bil, LDH or ALP are more than two times greater than upper limit of normal range) confirmed or clinically suspected myocardial infarction and/or congestive heart failure prescribed medicines for diabetes mellitus and/or hypertension pasthistory for hypersensitivities and/or allargic reactions against Cefcapene Pivoxil Hydrochloride Hydrate or ingredients of Flomox(R) Past history of hypersensitivities for Cephalosporins
研究者
相似试验
已完成
不适用
Genome analysis on drug adverse reactioMalignant diseasesJPRN-UMIN000015784Department of Medical Oncology Graduate School of Medicine, Chiba University55
招募中
不适用
A pharmacogenomics study for adverse effects and clinical outcome to S-1 in gastric cancer patientsgastric cancerJPRN-UMIN000004968Department of Clinical Pharmacology and Genitics, School of Pharmaceutical Science, Univercity of Shizuoka100
尚未招募
不适用
Predicting side effects occurred in hospitalized older patients using Artificial Intelligence(AI)CTRI/2019/08/020834Viola Savy Dsouza
尚未招募
不适用
A study to identify clinical and inborn risk factors for development of vision impairment in patients on Ethambuol, an antituberculosis drugCTRI/2022/08/045044Duke NUS Program Grant Award
尚未招募
不适用
Predictive value of drug elimination gene polymorphisms on clearance and dose adjustment of sunitinib (Sutent, SU11248) in patients with cancerCancer treated with sunitinib10027655NL-OMON32880Academisch Medisch Centrum10